Blood test could predict Alzheimer's risk before symptoms show
NCT ID NCT06043700
First seen Jan 07, 2026 · Last updated May 25, 2026 · Updated 21 times
Summary
This study aims to see if a blood test can identify people who may have amyloid buildup in the brain, a hallmark of Alzheimer's disease. Researchers will test 2,000 adults aged 50-80, with or without memory symptoms, to sort them into low, medium, or high risk groups. The goal is to make early detection easier and more accessible than current brain scans or spinal taps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eisai Site #1
Lady Lake, Florida, 32159, United States
-
Eisai Site #2
District Heights, Maryland, 20747, United States
-
Eisai Site #3
Clermont, Florida, 34711, United States
Conditions
Explore the condition pages connected to this study.